FR2938437B1 - Utilisation cosmetique de microorganisme pour le traitement des peaux grasses - Google Patents

Utilisation cosmetique de microorganisme pour le traitement des peaux grasses Download PDF

Info

Publication number
FR2938437B1
FR2938437B1 FR0857866A FR0857866A FR2938437B1 FR 2938437 B1 FR2938437 B1 FR 2938437B1 FR 0857866 A FR0857866 A FR 0857866A FR 0857866 A FR0857866 A FR 0857866A FR 2938437 B1 FR2938437 B1 FR 2938437B1
Authority
FR
France
Prior art keywords
microorganism
cosmetic use
treatment
oily skin
oily
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0857866A
Other languages
English (en)
French (fr)
Other versions
FR2938437A1 (fr
Inventor
Isabelle Castiel
Audrey Gueniche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
LOreal SA
Original Assignee
Societe des Produits Nestle SA
Nestec SA
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0857866A priority Critical patent/FR2938437B1/fr
Application filed by Societe des Produits Nestle SA, Nestec SA, LOreal SA filed Critical Societe des Produits Nestle SA
Priority to PCT/IB2009/053204 priority patent/WO2010013179A1/en
Priority to ES09802596.8T priority patent/ES2524367T3/es
Priority to PT98025968T priority patent/PT2306970E/pt
Priority to PL09802596T priority patent/PL2306970T3/pl
Priority to BRPI0916693A priority patent/BRPI0916693A2/pt
Priority to JP2011520636A priority patent/JP2011529484A/ja
Priority to EP09802596.8A priority patent/EP2306970B1/en
Priority to CN200980129348.8A priority patent/CN102105132B/zh
Priority to US13/056,344 priority patent/US8951775B2/en
Publication of FR2938437A1 publication Critical patent/FR2938437A1/fr
Application granted granted Critical
Publication of FR2938437B1 publication Critical patent/FR2938437B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR0857866A 2008-07-29 2008-11-19 Utilisation cosmetique de microorganisme pour le traitement des peaux grasses Expired - Fee Related FR2938437B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR0857866A FR2938437B1 (fr) 2008-11-19 2008-11-19 Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
CN200980129348.8A CN102105132B (zh) 2008-07-29 2009-07-23 微生物用于治疗油性皮肤的美容应用
PT98025968T PT2306970E (pt) 2008-07-29 2009-07-23 Uso cosmético de lactobacillus paracasei para o tratamento de pele oleosa
PL09802596T PL2306970T3 (pl) 2008-07-29 2009-07-23 Zastosowanie kosmetyczne Lactobacillus paracasei w leczeniu skóry tłustej
BRPI0916693A BRPI0916693A2 (pt) 2008-07-29 2009-07-23 uso de uma quantidade eficaz de pelo menos um microorganismo probiótico, composição cosmética e/ou dermatológica, e, método de tratamento cosmético
JP2011520636A JP2011529484A (ja) 2008-07-29 2009-07-23 油性皮膚の処置の為の微生物の化粧的使用
PCT/IB2009/053204 WO2010013179A1 (en) 2008-07-29 2009-07-23 Cosmetic use of microorganisms for the treatment of oily skin
ES09802596.8T ES2524367T3 (es) 2008-07-29 2009-07-23 Uso cosmético de Lactobacillus paracasei para el tratamiento de la piel grasa
US13/056,344 US8951775B2 (en) 2008-07-29 2009-07-23 Cosmetic use of microorganisms for the treatment of oily skin
EP09802596.8A EP2306970B1 (en) 2008-07-29 2009-07-23 Cosmetic use of Lactobacillus paracasei for the treatment of oily skin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0857866 2008-11-19
FR0857866A FR2938437B1 (fr) 2008-11-19 2008-11-19 Utilisation cosmetique de microorganisme pour le traitement des peaux grasses

Publications (2)

Publication Number Publication Date
FR2938437A1 FR2938437A1 (fr) 2010-05-21
FR2938437B1 true FR2938437B1 (fr) 2020-03-27

Family

ID=40834534

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0857866A Expired - Fee Related FR2938437B1 (fr) 2008-07-29 2008-11-19 Utilisation cosmetique de microorganisme pour le traitement des peaux grasses

Country Status (10)

Country Link
US (1) US8951775B2 (enExample)
EP (1) EP2306970B1 (enExample)
JP (1) JP2011529484A (enExample)
CN (1) CN102105132B (enExample)
BR (1) BRPI0916693A2 (enExample)
ES (1) ES2524367T3 (enExample)
FR (1) FR2938437B1 (enExample)
PL (1) PL2306970T3 (enExample)
PT (1) PT2306970E (enExample)
WO (1) WO2010013179A1 (enExample)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9642877B1 (en) * 2016-01-06 2017-05-09 Kenneth O. Russell Method of administration of chromium and magnesium sulfate for treatment of acne
FR2953407B1 (fr) * 2009-12-08 2013-06-14 Oreal Microorganismes probiotiques a titre d'actif contre les alterations du microrelief
FR2953408B1 (fr) * 2009-12-08 2013-02-08 Oreal Microorganismes probiotiques a titre d'actif pour l'eclat du teint de la peau
US8465731B2 (en) * 2010-03-12 2013-06-18 Elc Management, Llc Probiotic color cosmetic compositions and methods
CN102477446B (zh) * 2010-11-25 2014-03-19 花王株式会社 神经酰胺和/或葡萄糖神经酰胺产生促进剂的制造方法
CN102994558B (zh) * 2011-09-15 2014-07-16 花王株式会社 神经酰胺产生促进剂的制造方法
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US10111913B2 (en) 2011-02-04 2018-10-30 Joseph E. Kovarik Method of reducing the likelihood of skin cancer in an individual human being
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US10583033B2 (en) 2011-02-04 2020-03-10 Katherine Rose Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US10835560B2 (en) 2013-12-20 2020-11-17 Joseph E. Kovarik Reducing the likelihood of skin cancer in an individual human being
US10842834B2 (en) 2016-01-06 2020-11-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US9987224B2 (en) 2011-02-04 2018-06-05 Joseph E. Kovarik Method and system for preventing migraine headaches, cluster headaches and dizziness
US10086018B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US10085938B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for preventing sore throat in humans
US11191665B2 (en) 2011-02-04 2021-12-07 Joseph E. Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US10512661B2 (en) 2011-02-04 2019-12-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US10010568B2 (en) 2011-02-04 2018-07-03 Katherine Rose Kovarik Method and system for reducing the likelihood of a spirochetes infection in a human being
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
US11419903B2 (en) 2015-11-30 2022-08-23 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US10245288B2 (en) 2011-02-04 2019-04-02 Joseph E. Kovarik Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US11273187B2 (en) 2015-11-30 2022-03-15 Joseph E. Kovarik Method and system for reducing the likelihood of developing depression in an individual
US10940169B2 (en) 2015-11-30 2021-03-09 Joseph E. Kovarik Method for reducing the likelihood of developing cancer in an individual human being
US10548761B2 (en) 2011-02-04 2020-02-04 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US10687975B2 (en) 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
JP5774884B2 (ja) * 2011-03-29 2015-09-09 日本メナード化粧品株式会社 アクネ菌のバイオフィルム形成阻害剤
WO2012150269A1 (en) * 2011-05-03 2012-11-08 Dupont Nutrition Biosciences Aps Probiotic bacteria for the topical treatment of skin disorders
KR20140094563A (ko) * 2011-10-25 2014-07-30 아치 퍼스널 케어 프로덕츠, 엘.피. 연속 또는 동시 발효의 추출물을 함유하는 조성물
GB201206599D0 (en) * 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
CN102755281A (zh) * 2012-07-13 2012-10-31 无锡紫昂生物科技有限公司 一种含有微生物调节剂的化妆品
FR2996452B1 (fr) * 2012-10-05 2017-01-13 Oreal Propionibacterium freudenreichii en tant qu'actif contre les peaux grasses a tendance acneique
FR2996451B1 (fr) * 2012-10-05 2015-09-04 Oreal Propionibacterium freudenreichii en tant qu'actif cosmetique contre les peaux grasses
US12318377B2 (en) 2013-12-20 2025-06-03 Seed Health, Inc. Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US11213552B2 (en) 2015-11-30 2022-01-04 Joseph E. Kovarik Method for treating an individual suffering from a chronic infectious disease and cancer
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US11642382B2 (en) 2013-12-20 2023-05-09 Seed Health, Inc. Method for treating an individual suffering from bladder cancer
US11529379B2 (en) 2013-12-20 2022-12-20 Seed Health, Inc. Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US12329783B2 (en) 2013-12-20 2025-06-17 Seed Health, Inc. Method and system to improve the health of a person's skin microbiome
US11026982B2 (en) 2015-11-30 2021-06-08 Joseph E. Kovarik Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11672835B2 (en) 2013-12-20 2023-06-13 Seed Health, Inc. Method for treating individuals having cancer and who are receiving cancer immunotherapy
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis
ES3025685T3 (en) 2014-06-17 2025-06-09 Crown Laboratories Inc Genetically modified bacteria and methods for genetic modification of bacteria
RU2753125C2 (ru) * 2015-07-02 2021-08-11 Аобиом Ллк Окисляющие аммиак бактерии для лечения угревой сыпи
ITUB20153106A1 (it) * 2015-08-13 2017-02-13 Probiotical Spa Composizione di batteri lattici per uso nel trattamento delle infezioni causate da Propionibacterium acnes e in particolare per l'acne
EP3362038A4 (en) * 2015-10-15 2019-05-15 Natura Cosméticos S.A. COSMETIC COMPOSITION WITH PROBIOTIC BACTERIA
US10675347B2 (en) 2015-11-30 2020-06-09 Joseph E. Kovarik Method and system for protecting honey bees from fipronil pesticides
US10568916B2 (en) 2015-11-30 2020-02-25 Joseph E. Kovarik Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
US10086024B2 (en) 2015-11-30 2018-10-02 Joseph E. Kovarik Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides
US10933128B2 (en) 2015-11-30 2021-03-02 Joseph E. Kovarik Method and system for protecting honey bees from pesticides
US12239706B2 (en) 2015-11-30 2025-03-04 Seed Health, Inc. Method and system for protecting monarch butterflies from pesticides
US11529412B2 (en) 2015-11-30 2022-12-20 Seed Health, Inc. Method and system for protecting honey bees from pesticides
JP6185041B2 (ja) * 2015-12-04 2017-08-23 一丸ファルコス株式会社 表皮ブドウ球菌由来のグリセロール産生促進剤、皮膚表皮角化細胞由来の抗菌ペプチド産生促進剤、およびそれらの皮膚保護用外用剤への利用
LT6463B (lt) 2015-12-10 2017-10-10 Uab "Probiosanus" Probiotinių bakterijų (pb) gyvybingumo ir stabilumo padidinimas detergentų turinčiuose asmens higienos ir buities priežiūros produktuose
US11504404B2 (en) 2016-02-24 2022-11-22 Crown Laboratories, Inc. Skin probiotic formulation
AU2017240068B2 (en) 2016-03-31 2022-12-15 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
JP2019510036A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティクス／プレバイオティクス有効成分を含む清浄剤組成物
JP2019514885A (ja) 2016-04-21 2019-06-06 ネイキッド バイオーム，インク． 皮膚障害の処置のための組成物および方法
US11382939B2 (en) 2016-09-15 2022-07-12 Kirin Holdings Kabushiki Kaisha Composition which contains lactic acid bacterium as effective component and which is for preventing or ameliorating skin condition deterioration caused by abnormal proliferation of specific bacterium in skin
CN106265479A (zh) * 2016-10-27 2017-01-04 广州仙施生物科技有限公司 一种皮肤修复组合物及其制备方法
US10258567B1 (en) 2016-11-17 2019-04-16 Grace Procurements Llc Vaginal probiotic products and related processes
CA3043748A1 (en) 2016-11-23 2018-05-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
WO2018109018A1 (fr) * 2016-12-16 2018-06-21 Nestle Skin Health Sa Capsule comprenant un microorganisme probiotique pour utilisation dans un dispositif de production et de distribution de compositions
JP6994214B2 (ja) * 2017-05-01 2022-02-21 日本コルマー株式会社 皮膚改善用食品組成物
JP7402689B2 (ja) * 2017-05-08 2023-12-21 ロレアル ケラチン基質細菌叢を改変するための化学または有機化合物でのコールド大気圧プラズマ処置
KR102288897B1 (ko) * 2017-06-06 2021-08-12 새미 랩스 리미티드 바실러스 코아귤런스의 세포외 대사물질 조제물을 함유하는 모발 관리 조성물
KR102394642B1 (ko) 2017-09-15 2022-05-09 (주)아모레퍼시픽 바실러스 화진포엔시스의 배양물 또는 이의 추출물을 포함하는 피부 미백용 조성물
CN111511379B (zh) * 2017-12-06 2024-06-18 Lac2生物群系有限公司 基于益生菌的组合物及其应用
WO2020055547A2 (en) 2018-08-18 2020-03-19 Seed Health, Inc. Methods and compositions for honey bee health
CN111374896A (zh) * 2018-12-28 2020-07-07 西安臻瑞生物科技有限公司 一种治疗痤疮的益生元和益生菌护肤品及其制备方法
WO2020150329A1 (en) * 2019-01-15 2020-07-23 Microbiome Labs, Llc Spore-based probiotic composition for modulation of dermal and sub-dermal properties
AU2019427475B2 (en) 2019-01-31 2025-01-09 Kimberly-Clark Worldwide, Inc. Methods and products for dynamic control of environments by selective metabolic function of microbes
CN110093286B (zh) * 2019-03-19 2021-12-17 江南大学 假小链双歧杆菌ccfm1046、其组合物、发酵食品、用途、菌剂及其菌剂制备方法
CL2019000845A1 (es) * 2019-03-29 2019-08-30 Monje Marcela Maritza Espinoza Formulación probiótica que comprende cepas weissella viridescens aisladas desde helix aspersa müller y su uso para la prevención y tratamiento coadyuvante del acné vulgar
KR102058622B1 (ko) 2019-08-27 2019-12-23 주식회사 아미코스메틱 여드름 유발 피부상재균에 대한 항균 활성을 갖는 락토바실러스 쿠르바투스
CN110507598A (zh) * 2019-09-10 2019-11-29 河北一然生物科技有限公司 乳酸菌在抑制痤疮丙酸杆菌中的应用及用其制成的护肤品
CN111202709A (zh) * 2019-12-11 2020-05-29 河北一然生物科技有限公司 一种能够抑制痤疮丙酸杆菌的乳酸菌面膜及制备方法
KR102277957B1 (ko) * 2020-03-11 2021-07-16 주식회사 엘지생활건강 피부 유익균 증진용 화장료 조성물
JP2023533202A (ja) 2020-06-23 2023-08-02 クラウン ラボラトリーズ，インコーポレイテッド プロバイオティクス皮膚製剤
KR102244812B1 (ko) * 2020-09-23 2021-04-28 (주)에스디생명공학 락토바실러스 플란타룸 아종 플란타룸 sdcm 1002 및 사카로마에세스 세르비지에 sdcm 3017의 혼합 균주, 그 배양액, 또는 이의 추출물을 유효성분으로 포함하는 조성물
US20220110918A1 (en) * 2020-10-09 2022-04-14 Script Essentials, Llc Compositions and methods for treatment of skin-related diseases and promoting dermatological health
CN116568292A (zh) * 2020-11-05 2023-08-08 莱托生物股份有限公司 用于治疗皮肤病症的新组合物
KR102643628B1 (ko) * 2020-12-10 2024-03-04 민흥기 유산균을 함유하는 비립종 개선용 조성물
FR3124077B1 (fr) * 2021-06-22 2025-05-02 Univ Nanyang Tech Utilisation d ’ un acide gras à cha î ne courte comme agent antipelliculaire
BR112023012330A2 (pt) * 2020-12-21 2023-11-14 Oreal Usos cosméticos e processos cosméticos
JP2024505253A (ja) * 2021-02-01 2024-02-05 アジトラ インコーポレーテッド 遺伝子操作された細菌中でのタンパク質発現を増加させるための方法および組成物
CN113632990A (zh) * 2021-09-03 2021-11-12 上海楷达生物科技有限公司 一种能促进玻尿酸和胶原合成的美容益生菌组合物
CN114717134B (zh) * 2021-11-15 2023-11-21 青岛蔚蓝生物股份有限公司 一株乳双歧杆菌及其在防治痤疮中的应用
CN117363528A (zh) * 2023-06-27 2024-01-09 深圳市波尔顿科技有限公司 具有肠炎治疗作用的长双歧杆菌及其应用
CN118325798B (zh) * 2024-06-17 2024-08-30 青岛诺和诺康生物科技有限公司 一株减少头皮屑及毛囊炎的鼠李糖乳酪杆菌nhnk-604及其制品和应用
KR102829083B1 (ko) * 2024-09-11 2025-07-04 일동바이오사이언스(주) 여드름 개선을 위한 비피도박테리움 비피덤 idcc 4201 균주를 포함하는 조성물 및 건강기능식품

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1136429A (zh) * 1995-01-24 1996-11-27 康白 微生态制剂美容霜及其制备方法
ES2255730T3 (es) * 1997-04-18 2006-07-01 Ganeden Biotech, Inc. Utilizacion topica de esporas de bacilos probioticos para prevenir o tratar las infecciones microbianas.
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
WO2002028402A1 (en) 2000-10-06 2002-04-11 Société des Produits Nestlé S.A. Use of probiotic lactic acid bacteria for balancing the skin's immune system
AUPS057102A0 (en) * 2002-02-15 2002-03-07 Vri Biomedical Ltd Compositions and methods for treatment of skin disorders
ES2297181T3 (es) 2002-02-21 2008-05-01 Societe Des Produits Nestle S.A. Una composicion fotoprotectora para la piel, de administracion oral.
JP4037186B2 (ja) * 2002-06-21 2008-01-23 ニチニチ製薬株式会社 尋常性ざ瘡治療剤
EP1759597B1 (en) * 2003-03-13 2009-01-21 Kirin Holdings Kabushiki Kaisha Probiotic composition
JP5224807B2 (ja) * 2004-03-04 2013-07-03 イーエルシー マネージメント エルエルシー ラクトバチルス（Ｌａｃｔｏｂａｃｉｌｌｕｓ）抽出物による皮膚の処置方法
KR20070070153A (ko) * 2004-06-23 2007-07-03 로레알 민감성 및/또는 건성 피부의 예방 및/또는 치료에 유용한방법 및 조성물
FR2872047B1 (fr) * 2004-06-23 2007-06-15 Oreal Composition pour peaux sensibles associant cation mineral et probiotique(s)
JP5112069B2 (ja) * 2004-10-04 2013-01-09 ロレアル 敏感肌のための化粧品及び／または皮膚科組成物
FR2876029B1 (fr) * 2004-10-04 2008-11-14 Oreal Composition cosmetique et/ou dermatologique pour peaux sensibles.
US20060269508A1 (en) * 2005-03-29 2006-11-30 Trejo Amy V Means for regulating the cosmetic appearance and/or health of human keratinous tissue
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
JP2008061513A (ja) * 2006-09-04 2008-03-21 Himawari Nyugyo Kk 免疫バランスを正常化するラクトバチルス属乳酸菌及びそれを用いた飲食品
FR2908784B1 (fr) * 2006-11-17 2012-12-14 Oreal Utilisation cosmetique d'une proteine de la famille des ribonucleases
FR2912917B1 (fr) * 2007-02-26 2012-05-18 Oreal Milieu conditionne et ses utilisations
FR2920305B1 (fr) * 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
CN102131495B (zh) * 2008-07-29 2017-07-04 欧莱雅 微生物用于治疗头皮病症的美容应用
FR2937536B1 (fr) * 2008-10-28 2016-07-01 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement du cuir chevelu gras
FR2937547B1 (fr) * 2008-10-28 2012-11-09 Oreal Utilisation d'un lysat de microorganisme pour le traitement des peaux grasses

Also Published As

Publication number Publication date
US20110182861A1 (en) 2011-07-28
EP2306970B1 (en) 2014-09-10
FR2938437A1 (fr) 2010-05-21
PT2306970E (pt) 2014-12-17
ES2524367T3 (es) 2014-12-05
JP2011529484A (ja) 2011-12-08
PL2306970T3 (pl) 2015-03-31
CN102105132A (zh) 2011-06-22
US8951775B2 (en) 2015-02-10
CN102105132B (zh) 2014-12-10
EP2306970A1 (en) 2011-04-13
WO2010013179A1 (en) 2010-02-04
BRPI0916693A2 (pt) 2017-07-04

Similar Documents

Publication Publication Date Title
FR2938437B1 (fr) Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
MA31767B1 (fr) Composes organiques et leurs utilisations
FR2920304B1 (fr) Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
FR2959128B1 (fr) Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement des odeurs corporelles
MA33534B1 (fr) Anticorps humains d'affinité élevée dirigés contre l'angiopoïétine 2 humaine
MA33604B1 (fr) Composés et compositions en tant qu'inhibiteurs de protéine kinase
EP2033627A3 (fr) Utilisation d'un lysat de Bifidobacterium species pour le traitement de peaux sensibles
MA44549A1 (fr) Agents immunorègulateurs
MA31906B1 (fr) Inhibiteurs de la replication du virus de limmunodeficience humaine
EA201071245A1 (ru) Новые терапевтические подходы для лечения болезни альцгеймера и связанных нарушений посредством модулирования реакции клеток на стресс
TW200612926A (en) Compounds and compositions as ppar modulators
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
MA32131B1 (fr) Antagonistes aminoalkylbiphényle n, n' disubstitués des récepteurs d2 de la prostaglandine
MA33155B1 (fr) Composes organiques et leurs utilisations
MX2007009356A (es) Compuestos y composiciones como moduladores de ppar.
MA32506B1 (fr) Nouveaux composes
MA31435B1 (fr) Inhibition de metastases tumorales par des anticoprs anti-neuropiline 2
MA50406B1 (fr) Inhibiteurs pyrazole de magl
FR3076456B1 (fr) Huiles capillaires pour le traitement de fibres keratiniques
MA33457B1 (fr) L-sérine pour son utilisation en tant que médicament pour prévenir et/ou traiter une réaction inflammatoire de la peau
FR3004939B1 (fr) Huile essentielle de satureja montana a forte teneur en geraniol, et utilisation pour traiter les peaux grasses et/ou les defauts esthetiques associes
TW200724140A (en) Hydantoin compounds
MA38369B1 (fr) Peptides et compositions pour le traitement d'une lesion de l'articulation
FR2947727B1 (fr) Composition cosmetique a usage topique, trousse en comportant, procede cosmetique modulable en fonction du vieillissement de la peau la mettant en oeuvre
FR2952820B1 (fr) Procede de traitement cosmetique

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

TQ Partial transmission of property

Owner name: L'OREAL, FR

Effective date: 20190919

Owner name: SOCIETE DES PRODUITS NESTLE S.A., CH

Effective date: 20190919

PLFP Fee payment

Year of fee payment: 13

ST Notification of lapse

Effective date: 20220705